In vivo, it was recently found that RBM3 mediates the protective effects of hypothermia by reducing synaptic loss in a mouse model of Alzheimer's disease.13, 44 Therefore, we speculate that RBM3 induction in brains of PD patients may be a reasonable strategy for blocking PD progression caused by ROT. Here, RBM3 is linked to Parkinson disease.